Form 8-K - Current report:
SEC Accession No. 0001193125-23-040742
Filing Date
2023-02-16
Accepted
2023-02-16 08:13:48
Documents
56
Period of Report
2023-02-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d460344d8k.htm   iXBRL 8-K 33393
2 EX-99.1 d460344dex991.htm EX-99.1 14123
3 EX-99.2 d460344dex992.htm EX-99.2 50837
7 GRAPHIC g460344ex99_2s10g1.jpg GRAPHIC 379643
8 GRAPHIC g460344ex99_2s11g1.jpg GRAPHIC 368294
9 GRAPHIC g460344ex99_2s12g1.jpg GRAPHIC 370847
10 GRAPHIC g460344ex99_2s13g1.jpg GRAPHIC 324470
11 GRAPHIC g460344ex99_2s14g1.jpg GRAPHIC 337849
12 GRAPHIC g460344ex99_2s15g1.jpg GRAPHIC 356278
13 GRAPHIC g460344ex99_2s16g1.jpg GRAPHIC 334660
14 GRAPHIC g460344ex99_2s17g1.jpg GRAPHIC 382916
15 GRAPHIC g460344ex99_2s18g1.jpg GRAPHIC 392836
16 GRAPHIC g460344ex99_2s19g1.jpg GRAPHIC 296777
17 GRAPHIC g460344ex99_2s1g1.jpg GRAPHIC 380122
18 GRAPHIC g460344ex99_2s20g1.jpg GRAPHIC 115012
19 GRAPHIC g460344ex99_2s21g1.jpg GRAPHIC 318611
20 GRAPHIC g460344ex99_2s22g1.jpg GRAPHIC 281845
21 GRAPHIC g460344ex99_2s23g1.jpg GRAPHIC 103100
22 GRAPHIC g460344ex99_2s24g1.jpg GRAPHIC 353428
23 GRAPHIC g460344ex99_2s25g1.jpg GRAPHIC 374099
24 GRAPHIC g460344ex99_2s26g1.jpg GRAPHIC 343840
25 GRAPHIC g460344ex99_2s27g1.jpg GRAPHIC 136436
26 GRAPHIC g460344ex99_2s28g1.jpg GRAPHIC 360005
27 GRAPHIC g460344ex99_2s29g1.jpg GRAPHIC 391504
28 GRAPHIC g460344ex99_2s2g1.jpg GRAPHIC 626942
29 GRAPHIC g460344ex99_2s30g1.jpg GRAPHIC 309626
30 GRAPHIC g460344ex99_2s31g1.jpg GRAPHIC 383040
31 GRAPHIC g460344ex99_2s32g1.jpg GRAPHIC 267955
32 GRAPHIC g460344ex99_2s33g1.jpg GRAPHIC 119537
33 GRAPHIC g460344ex99_2s34g1.jpg GRAPHIC 263183
34 GRAPHIC g460344ex99_2s35g1.jpg GRAPHIC 45303
35 GRAPHIC g460344ex99_2s36g1.jpg GRAPHIC 106949
36 GRAPHIC g460344ex99_2s37g1.jpg GRAPHIC 310829
37 GRAPHIC g460344ex99_2s38g1.jpg GRAPHIC 382196
38 GRAPHIC g460344ex99_2s39g1.jpg GRAPHIC 283628
39 GRAPHIC g460344ex99_2s3g1.jpg GRAPHIC 326255
40 GRAPHIC g460344ex99_2s40g1.jpg GRAPHIC 345674
41 GRAPHIC g460344ex99_2s41g1.jpg GRAPHIC 359787
42 GRAPHIC g460344ex99_2s4g1.jpg GRAPHIC 287282
43 GRAPHIC g460344ex99_2s5g1.jpg GRAPHIC 353291
44 GRAPHIC g460344ex99_2s6g1.jpg GRAPHIC 447346
45 GRAPHIC g460344ex99_2s7g1.jpg GRAPHIC 160298
46 GRAPHIC g460344ex99_2s8g1.jpg GRAPHIC 356455
47 GRAPHIC g460344ex99_2s9g1.jpg GRAPHIC 321934
48 GRAPHIC g460344g0216042436762.jpg GRAPHIC 2605
  Complete submission text file 0001193125-23-040742.txt   17829016

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aura-20230216.xsd EX-101.SCH 2862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aura-20230216_lab.xml EX-101.LAB 17978
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aura-20230216_pre.xml EX-101.PRE 11266
50 EXTRACTED XBRL INSTANCE DOCUMENT d460344d8k_htm.xml XML 3339
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 23637203
SIC: 2836 Biological Products, (No Diagnostic Substances)